Changes To Anticipate In A Post-COVID Climate
By Michael Blackton, Michael Blackton, VP QA CMC at Adaptimmune
Just recently, I talked to Michael Blackton, VP QA CMC and John Lunger Chief Patient Supply Officer at Adaptimmune about COVID-19’s impact on the cell and gene sector. You can watch the full-length video here.
I’ve also broken down the interview into bite-size chunks, and I think you’ll find this exchange valuable. Here, Blackton and Lunger discuss the changes to anticipate in the post-COVID climate.
This website uses cookies to ensure you get the best experience on our website. Learn more